T Cell Signaling and Activation | Immunology Lecture (UCSD Extension)

Added:

The Mechanosensor Model of TCR Activation

Traditional immunology models explain T Cell Receptor (TCR) activation through chemical affinity, conformational changes, or kinetic segregation upon binding to peptide-MHC complexes. However, the Mechanosensor Model offers a critical alternative, proposing that physical force is a necessary trigger for TCR signaling. According to this perspective, the TCR acts as a mechanosensor. When a T cell interacts with an antigen-presenting cell, physical shear force and tension convert the TCR-ligand interaction into a 'catch bond' (which strengthens under pull) rather than a 'slip bond'. This mechanical strain induces conformational changes in the CD3 complex required to initiate downstream intracellular signaling. Proponents of this model argue that purely chemical, affinity-based models cannot fully explain the extreme sensitivity and rapid discrimination of T cells, making biophysical forces a vital, often overlooked component of T cell activation.

Basic T cell biology, including the roles and differentiation of CD4+ (helper) and CD8+ (cytotoxic) T cells.
The mechanism of antigen presentation, specifically how Antigen-Presenting Cells (APCs) process and present peptides via MHC Class I and Class II molecules.
The basic structure and components of the T Cell Receptor (TCR) and its associated CD3 complex.
Fundamental cellular signaling concepts, such as receptor-ligand interactions, phosphorylation cascades (kinases and phosphatases), and second messengers.
Downstream transcription factor activation (e.g., NFAT, NF-kB, and AP-1) and their role in driving cytokine gene expression like IL-2.
T cell clonal expansion, differentiation into distinct effector subsets (such as Th1, Th2, Th17, and Treg), and memory cell generation.
The structure and function of the immunological synapse formed between T cells and antigen-presenting cells.
Clinical applications, including the mechanism of immunosuppressive drugs (e.g., cyclosporine, tacrolimus) and modern immunotherapies like CAR-T and checkpoint inhibitors (PD-1/CTLA-4 blockade).
22.6K views363likes27:47@annelisesnyder4364Original Release: 2021-03-17

T cell activation requires coordinated signaling through the T cell receptor (TCR) and co-stimulatory molecules (signal 2), where TCR binding to peptide-MHC complexes activates ZAP-70 kinase, which initiates four signaling modules involving PLC gamma that generate second messengers (IP3 and DAG) to activate transcription factors NFAT, AP-1, and NF-kappaB, all converging on IL-2 production; co-stimulation through CD28 enhances these pathways by generating PIP3, which is essential for optimal T cell activation and effector function.